Gout
Conference Coverage
Poor control of serum urate linked to cardiovascular risk in patients with gout
A new study of medical records adds to the evidence linking gout, particularly in patients with poorly controlled serum urate level, to...
Conference Coverage
Research ties gout in women to comorbidities more than genetics
Research suggests a link between cardiometabolic comorbidities and obesity and gout in women, with genetic traits seen playing a lesser role.
Feature
Worse COVID outcomes seen with gout, particularly in women
People with gout, especially women, may be at higher risk for poor COVID-19 outcomes, including hospitalization and death, researchers report.
From the Journals
Could vitamin C help reduce gout?
A post hoc analysis of data from a randomized, double-blind, placebo-controlled study of more than 14,000 male doctors showed that 500 mg of...
20th Anniversary
OMERACT continues to set standards on research outcomes, enhancing the patient voice
OMERACT arose from a need to streamline clinical outcome measures in rheumatology, and now with 30 years of...
Conference Coverage
ALL-HEART: No benefit of allopurinol in ischemic heart disease
Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was ‘definitively neutral’ in...
From the Journals
Low urate limits for gout questioned in study
Low urate levels appear less risky when body composition is figured into the statistical analysis.
From the Journals
Ultrasound helps predict gout flares over the next year
Ultrasound findings of urate deposits and inflammation may predict gout flares over the next year, researchers in Italy and the UK report.
From the Journals
Black Americans’ high gout rate stems from social causes
Primary care providers need to address disparities through more comprehensive care and referrals to rheumatologists.
From the Journals
Gout flares linked to transient jump in MI, stroke risk
Causation is plausible, even suspected, say experts, who urge aggressive CV risk-factor management in gout patients and perhaps more willingness...
Latest News
Benzbromarone tops febuxostat for gout?
Benzbromarone is not approved in the United States because of concerns of acute liver injury but is approved in several other countries.